Avidity Biosciences
RNA
#1832
Rank
A$16.16 B
Marketcap
A$107.30
Share price
0.06%
Change (1 day)
87.46%
Change (1 year)

Market capitalization of Avidity Biosciences (RNA)

Market cap: A$16.16 Billion

As of December 2025 Avidity Biosciences has a market cap of A$16.16 Billion. This makes Avidity Biosciences the world's 1832th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Avidity Biosciences from 2020 to 2025

End of year Market Cap

Year Marketcap Change
2025A$16.16 B179.93%
2024A$5.77 B449.14%
2023A$1.05 B-51.47%
2022A$2.16 B40.95%
2021A$1.53 B23.46%
2020A$1.24 B

End of Day market cap according to different sources

On Dec 9th, 2025 the market cap of Avidity Biosciences was reported to be:

A$16.16 Billion
by Nasdaq info icon info icon
A$16.16 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
PTC Therapeutics
PTCT
A$8.87 B-45.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
A$1.23 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
A$3.49 B-78.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
A$4.17 B-74.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
A$0.18 B-98.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
A$16.45 B 1.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$216.73 B 1,240.56%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
A$144.10 B 791.30%๐Ÿ‡ฌ๐Ÿ‡ง UK